ArticleBMJ open2026

Determination of central pain modulation biomarkers to characterise patients with cancer and refractory pain: protocol for a cross-sectional study.

Lara Rubal-Otero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.